4//SEC Filing
Sherman Matthew L 4
Accession 0001209191-23-053939
CIK 0001654151other
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 4:11 PM ET
Size
6.7 KB
Accession
0001209191-23-053939
Insider Transaction Report
Form 4
Sherman Matthew L
EVP & Chief Medical Officer
Transactions
- Sale
Common Stock
2023-10-30$12.02/sh−2,360$28,362→ 90,628 total - Award
Common Stock
2023-10-28+8,244→ 92,988 total
Footnotes (2)
- [F1]On February 15, 2023, the Reporting Person was granted restricted stock units ("RSUs"), which vest upon the satisfaction of three performance criteria. On October 28, 2023, the Issuer's Compensation Committee confirmed that performance criteria two had been met, resulting in the vesting of 8,244 RSUs.
- [F2]This sale was to cover tax liabilities in the vesting of RSUs.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001325710
Filing Metadata
- Form type
- 4
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 4:11 PM ET
- Size
- 6.7 KB